丹纳赫收购NobelBiocare控制其97％股票

　　2014年12月11日，丹纳赫宣布即将完成收购Nobel Biocare公司目前公开发行的股票。附加承诺期已于2014年12月4日到期。

　　丹纳赫现在已控制Nobel Biocare大约97%的股票。

　　2015年第一季度，丹纳赫计划要求注销Nobel Biocare未完成的公众持有记名股票。此外，丹纳赫可能决定将Nobel Biocare排除合并为丹纳赫所掌控的公司。无论哪种方案下，丹纳赫预计余下的股东将获得每股不超过17.1的瑞士法郎（这是公开要约支付价格）。

　　由于瑞士最优惠价格规则，附加承诺期（2014年12月4日）的到期后六个月内继续申请，丹纳赫可以不支付超过每股17.10瑞士法郎的Nobel Biocare在公开市场以其他方式购买的任何股份。

　　此外，丹纳赫计划将Nobel Biocare将从瑞士证券交易所退市。

Danaher Completes Acquisition Of Nobel Biocare

　　WASHINGTON, Dec. 11, 2014 /PRNewswire/  --Danaher Corporation (DHR) announces that today it will settle the public tender offer for all the registered shares of Nobel Biocare Holding AG ("Nobel Biocare").The additional acceptance period for the tender offer expired on December 4, 2014.

　　Danaher now controls approximately 97% of the issued registered shares of Nobel Biocare.

　　Sometime in the first quarter of 2015, Danaher intends to request the cancellation of the outstanding publicly held registered shares of Nobel Biocare. Alternatively, Danaher may decide to initiate a squeeze-out merger of Nobel Biocare into a company controlled by Danaher. In either such squeeze-out case, Danaher anticipates that the remaining shareholders will receive no more than CHF 17.10 per share (which is the consideration paid in the public tender offer).

　　Due to the Swiss best price rule that continues to apply during the six months following the end of the additional acceptance period (December 4, 2014) of the public tender offer, Danaher may not pay more than CHF 17.10 per share for any remaining shares of Nobel Biocare purchased in the open market or otherwise.

　　Furthermore, Danaher intends to have Nobel Biocare apply with SIX Swiss Exchange ("SIX") for the de-listing of the registered shares of Nobel Biocare in accordance with the listing rules of SIX and for an exemption of certain disclosure obligations under the listing rules of SIX until the date of de-listing of the registered shares of Nobel Biocare.

　　About Danaher

　　Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands have unparalleled leadership positions in some of the most demanding and attractive industries, including health care, environmental and industrial. The company's globally diverse team of 66,000 associates is united by a common culture and operating system, the Danaher Business System. In 2013, Danaher generated $19.1 billion in revenue and its market capitalization exceeded $50 billion. For more information please visit

　　www.danaher.com.